Resveratrol attenuates the inflammatory reaction induced by ischemia/reperfusion in the rat heart

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2528-2532

  Cong, Xiaoqiang ^a,b   Li, Ying ^c   Lu, Na ^a   Dai, Yajian ^d   Zhang, Huijie ^d   Zhao, Xin ^a   Liu, Ya ^b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c People's Hospital of Jilin Province   (China)

^d Linjiang Hospital   (China)

Author keywords

Ischemia reperfusion injury; Neutrophil; Resveratrol; Tumor necrosis factor

Indexed keywords

CREATINE KINASE; CYCLIC GMP; LACTATE DEHYDROGENASE; METHYLENE BLUE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HEART INFARCTION; HEART MUSCLE; HEART PROTECTION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CREATINE KINASE; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NEUTROPHIL INFILTRATION; RATS; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899679703     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2090     Document Type: Article

References (34)

1. Xiong J, Xue FS, Yuan YJ, Wang Q, Liao X and Wang WL: Cholinergic anti-inflammatory pathway: a possible approach to protect against myocardial ischemia reperfusion injury. Chin Med J (Engl) 123: 2720-2726, 2010.
2. Naidu BV, Farivar AS, Woolley SM, et al: Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury. J Heart Lung Transplant 23: 128-134, 2004. (Pubitemid 38084839)
3. Renaud S and de Lorgeril M: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526, 1992.
4. Athar M, Back JH, Tang X, et al: Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224: 274-283, 2007. (Pubitemid 47575677)
5. Aluyen JK, Ton QN, Tran T, et al: Resveratrol: potential as anticancer agent. J Diet Suppl 9: 45-56, 2012.
6. Piotrowska H, Myszkowski K, Ziółkowska A, et al: Resveratrol analogue 3,4,4′,5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells. Toxicol Appl Pharmacol 263: 53-60, 2012.
7. Afaq F, Adhami VM and Ahmad N: Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol Appl Pharmacol 186: 28-37, 2003. (Pubitemid 36262946)
8. Sehirli O, Sakarcan A, Velioǧlu-Oǧünç A, et al: Resveratrol improves ifosfamide-induced Fanconi syndrome in rats. Toxicol Appl Pharmacol 222: 33-41, 2007. (Pubitemid 46962655)
9. Xu Y, Nie L, Yin YG, et al: Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells. Toxicol Appl Pharmacol 259: 395-401, 2012.
10. Li F, Gong Q, Dong H and Shi J: Resveratrol, a neuroprotective supplement for Alzheimer's disease. Curr Pharm Des 18: 27-33, 2012.
11. López-Miranda V, Soto-Montenegro ML, Vera G, et al: Resveratrol: a neuroprotective polyphenol in the Mediterranean diet. Rev Neurol 54: 349-356, 2012 (In Spanish).
12. Lanzilli G, Cottarelli A, Nicotera G, et al: Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 35: 240-248, 2012.
13. Black SC and Rodger IW: Methods for studying experimental myocardial ischemic and reperfusion injury. J Pharmacol Toxicol Methods 35: 179-190, 1996. (Pubitemid 26249097)
14. Speyer CL and Ward PA: Role of endothelial chemokines and their receptors during inflammation. J Invest Surg 24: 18-27, 2011.
15. Khimenko PL, Bagby GJ, Fuseler J and Taylor AE: Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol (1985) 85: 2005-2011, 1998.
16. Batista ML Jr, Rosa JC, Lopes RD, et al: Exercise training changes IL-10/TNF-alpha ratio in the skeletal muscle of post-MI rats. Cytokine 49: 102-108, 2010.
17. Zhu J, Liu M, Kennedy RH and Liu SJ: TNF-alpha-induced impairment of mitochondrial integrity and apoptosis mediated by caspase-8 in adult ventricular myocytes. Cytokine 34: 96-105, 2006. (Pubitemid 43817557)
18. Meldrum DR, Cleveland JC Jr, Cain BS, Meng X and Harken AH: Increased myocardial tumor necrosis factor-alpha in a crystalloid- perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg 65: 439-443, 1998. (Pubitemid 28083341)
19. Gurevitch J, Frolkis I, Yuhas Y, et al: Antitumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 30: 1554-1561, 1997. (Pubitemid 27486476)
20. Lefer AM, Ma XL, Weyrich A and Lefer DJ: Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. Agents Actions Suppl 41: 127-135, 1993. (Pubitemid 23149622)
21. Schwartz BG and Kloner RA: Coronary no reflow. J Mol Cell Cardiol 52: 873-882, 2012.
22. Ma XL, Lefer DJ, Lefer AM and Rothlein R: Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 86: 937-946, 1992.
23. Chandrasekar B, Smith JB and Freeman GL: Ischemia-reperfusion of rat myocardium activates nuclear factor-kappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 103: 2296-2302, 2001. (Pubitemid 32433721)
24. Liu P, Hock CE, Nagele R and Wong PY: Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol 272: H2327-H2336, 1997.
25. Li J, Wu F, Zhang H, et al: Insulin inhibits leukocyte-endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol 47: 512-519, 2009.
26. Li J, Zhang H, Wu F, et al: Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med 36: 1551-1558, 2008. (Pubitemid 351620675)
27. Alcendor RR, Gao S, Zhai P, et al: Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100: 1512-1521, 2007. (Pubitemid 46834764)
28. Danz ED, Skramsted J, Henry N, Bennett JA and Keller RS: Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic Biol Med 46: 1589-1597, 2009.
29. Pillai JB, Isbatan A, Imai S and Gupta MP: Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. J Biol Chem 280: 43121-43130, 2005. (Pubitemid 43049278)
30. Wallerath T, Li H, Godtel-Ambrust U, Schwarz PM and Forstermann U: Blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 12: 97-104, 2005. (Pubitemid 40312451)
31. Penumathsa SV, Thirunavukkarasu M, Koneru S, et al: Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol 42: 508-516, 2007. (Pubitemid 46349117)
32. Rush JW, Quadrilatero J, Levy AS and Ford RJ: Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med (Maywood) 232: 814-822, 2007. (Pubitemid 46827824)
33. Beher D, Wu J, Cumine S, et al: Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des 74: 619-624, 2009.
34. Chakrabarty SP, Balaram H and Chandrasekaran S: Sirtuins: multifaceted drug targets. Curr Mol Med 11: 709-718, 2011.